Review: taking Warfarin sodium and Magnesium citrate together


Summary

Drug interactions are reported among people who take Warfarin sodium and Magnesium citrate together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Magnesium citrate. It is created by eHealthMe based on reports of 1,141 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Warfarin sodium and Magnesium citrate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 48,040 users)

Magnesium Citrate

Magnesium citrate has active ingredients of magnesium. It is often used in constipation. (latest outcomes from Magnesium citrate 419 users)

On Jul, 28, 2016

1,141 people who take Warfarin Sodium, Magnesium Citrate are studied.


Number of reports submitted per year:

Warfarin sodium and Magnesium citrate drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 80.0% - (4 of 5 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 100.0% - (9 of 9 people)
  • not specified: 0.0% - (0 of 0 people)
Magnesium Citrate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 71.0% - (5 of 7 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 81.0% - (13 of 16 people)
  • male: 83.0% - (5 of 6 people)
Magnesium Citrate:
  • female: 61.0% - (8 of 13 people)
  • male: 83.0% - (5 of 6 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 71.0% - (5 of 7 people)
  • 60+: 92.0% - (12 of 13 people)
Magnesium Citrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 60.0% - (3 of 5 people)
  • 60+: 75.0% - (9 of 12 people)

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • renal failure
  • anaemia
  • anxiety
  • death
  • granulocytopenia
  • oral candidiasis
  • pain
  • injury
  • urinary tract infection
1 - 6 months:
  • anaemia
  • back pain
  • hepatitis acute
  • abdominal pain
  • decreased appetite
  • diarrhoea
  • faecal incontinence
  • nausea
  • female genital tract fistula
  • liver disorder
6 - 12 months:
  • decreased appetite
  • interstitial lung disease
  • pneumonia aspiration
  • anaemia
  • ascites
  • constipation
  • depression
  • disease progression
  • fatigue
  • gastrointestinal stromal tumour
1 - 2 years:
  • hives
  • itching
  • rash generalised
  • urticaria
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood lactate dehydrogenase increased
  • cold sweat
  • cough
  • dyspnoea
2 - 5 years:
  • muscle twitching
  • lightheadedness
  • muscle weakness
  • shaking palsy
  • vertigo positional
  • anaemia
  • atrial fibrillation
  • decreased appetite
  • dehydration
  • haematemesis
5 - 10 years:
  • lightheadedness
  • muscle twitching
  • muscle weakness
  • shaking palsy
  • vertigo positional
  • asthenia
  • cerebral infarction
  • disorientation
  • drug effect decreased
  • fatigue
10+ years:
  • hives
  • itching
  • rash generalised
  • urticaria
  • asthenia
  • disorientation
  • fatigue
  • muscle weakness aggravated
  • numbness and tingling
  • restless leg syndrome
not specified:
  • pain
  • anxiety
  • fatigue
  • anaemia
  • cardiac failure congestive
  • nausea
  • atrial fibrillation
  • dyspnoea
  • pneumonia
  • asthenia

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • anxiety
  • fatigue
  • asthenia
  • atrial fibrillation
  • diarrhoea
  • osteonecrosis of jaw
  • osteoarthritis
  • anaemia
male:
  • pain
  • cardiac failure congestive
  • anxiety
  • anaemia
  • pneumonia
  • dyspnoea
  • fatigue
  • gastrooesophageal reflux disease
  • atrial fibrillation
  • back pain

Most common drug interactions by age *:

20-29:
  • vomiting
  • insomnia
  • bronchitis
  • urinary tract infection
  • headache
  • atelectasis
  • dyspnoea
  • oedema peripheral
  • pain
  • asthenia
30-39:
  • pain
  • nephrogenic systemic fibrosis
  • oedema peripheral
  • extremity contracture
  • joint stiffness
  • skin hypertrophy
  • skin induration
  • deformity
  • joint range of motion decreased
  • motor dysfunction
40-49:
  • dyspnoea
  • pneumonia
  • pain
  • anaemia
  • fatigue
  • anxiety
  • deep vein thrombosis
  • asthenia
  • bone disorder
  • gastrooesophageal reflux disease
50-59:
  • osteoarthritis
  • arthralgia
  • pain
  • osteonecrosis of jaw
  • anxiety
  • oedema peripheral
  • cardiac failure congestive
  • fatigue
  • pleural effusion
  • pneumonia
60+:
  • anaemia
  • atrial fibrillation
  • pain
  • anxiety
  • nausea
  • cardiac failure congestive
  • back pain
  • fatigue
  • asthenia
  • dyspnoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Magnesium citrate?

Can you answer these questions?

More questions for: Warfarin sodium, Magnesium citrate

You may be interested in these reviews

More reviews for: Warfarin sodium, Magnesium citrate

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Magnesium citrate (magnesium) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.